Vaxxinact H5

Authorised

This medicine is authorised for use in the European Union

Avian influenza virus, subtype H5, haemagglutinin (recombinant)

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website. 

Product details

• Name of medicine:
  Vaxxinact H5
• Active substance:
  Avian influenza virus, subtype H5, haemagglutinin (recombinant)
• International non-proprietary name (INN) or common name:
  Avian influenza virus, subtype H5, haemagglutinin (recombinant)

Pharmacotherapeutic group

• Immunologicals for aves
• Domestic fowl
• Inactivated viral vaccines

Authorisation details

• EMA product number:
  EMEA/V/C/006717

Assessment history

Initial marketing authorisation documents

CVMP summary of positive opinion for Vaxxinact H5

Adopted Reference Number: EMA/CVMP/341546/2025